Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors

How Big Is The Biguanides Market Today And What Is Its Future Size?

The market size for biguanides has consistently shown expansion in the recent past. It is projected to surge from a value of $4.96 billion in 2024 to reach $5.11 billion by 2025, with a compound annual growth rate (CAGR) of 3.1%. Factors driving this growth during the historic period include an escalating demand for oral hypoglycemic medications, an increasing elderly population, a surge in obesity rates, as well as enhanced awareness regarding diabetes care.

A continuous upswing in the size of the biguanides market is projected over the coming years, ballooning to an estimated $5.81 billion in 2029 with a Compound Annual Growth Rate (CAGR) of 3.2%. This expected growth within the forecast period can be attributed to several factors including expanding combination therapies usage, breakthroughs in drug delivery technologies, heightened research and development investment, increased health expenditure, and evolving applications for treating polycystic ovary syndrome. Other trends expected to shape the market in the forecast period consist of shifting attention to the creation of extended-release formulations, a growing preference for fixed-dose combination therapies, a widening scope for applications within oncology, and the introduction of new biguanides known for their enhanced efficacy and safety.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15735&type=smp

What Core Drivers Are Expected To Influence The Biguanides Market?

The escalation of diabetes is anticipated to fuel the expansion of the biguanides market. Diabetes is a long-term metabolic ailment marked by elevated blood sugar levels due to the body’s insufficiency to generate adequate insulin. The increase in diabetes cases can be attributed to various factors, including alterations in lifestyle, aging population, genetic vulnerabilities, enhanced diagnosis, and environmental impacts. Biguanides like metformin are used to manage diabetes, as they enhance insulin sensitivity, lower glucose formation in the liver, and decrease blood sugar levels in type 2 diabetes patients. As a case in point, the Office for Health Improvement & Disparities in the UK reported in March 2024 that the proportion of individuals with type 1 diabetes receiving all eight prescribed care processes grew by 22%, and for those with type 2 diabetes by 21%, between March 2022 and March 2023. Furthermore, the percentage reaching the target HbA1c levels climbed to 37.9%, the maximum figure ever recorded. Hence, the increasing incidence of diabetes is contributing to the expansion of the biguanides market.

What Are The Main Segment Classifications In The Biguanides Market?

The biguanides market covered in this report is segmented –

1) By Type: Metformin, Phenformin, Other Types

2) By Dosage Form: Tablets, Oral Solutions

3) By Formulation: Immediate Release, Extended Release

4) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Subsegments:

1) By Metformin: Immediate-Release Metformin, Extended-Release Metformin

2) By Phenformin: Phenformin Hydrochloride

3) By Other Types: Buformin, Metformin Combinations

How Are Industry Trends Steering The Expansion Of The Biguanides Market?

Key players in the biguanide market are concentrating on the development of innovative solutions, such as extended-release biguanide medications, aimed at improving patient compliance, boosting therapeutic efficiency, and minimizing adverse effects. An extended-release biguanide is a medical formulation that releases its active ingredient gradually, securing steady blood concentrations and enhanced glycemic control for individuals with diabetes, thus improving persistence with treatment. For example, in August 2023, Dr. Reddy’s Laboratories, a biotech firm based in India, introduced saxagliptin and metformin hydrochloride extended-release drugs. This is a generic equivalent of KOMBIGLYZE XR, licensed by the US Food and Drug Administration (USFDA), which fuses saxagliptin, a DPP-4 inhibitor, with metformin, a biguanide. It is concocted to boost glycemic control in adults with type 2 diabetes mellitus and is expected to be used in conjunction with diet and exercise. The extended-release formulation assists in boosting patient compliance and effectiveness.

Who Are The Leading Companies Driving The Biguanides Market?

Major companies operating in the biguanides market are Cardinal Health Inc., Pfizer Inc., Merck And Co Inc., Bayer AG, Sanofi-Aventis LLC, AstraZeneca plc, Novartis AG, GlaxoSmithKline plc, Takeda Pharmaceuticals Company Limited, Novo Nordisk A/S, Viatris Inc., Daiichi Sankyo Company Limited, Wanbury Ltd., Boehringer Ingelheim International GmbH, Intas Pharmaceuticals Ltd., Aurobindo Pharma Ltd., Cipla Ltd., Shionogi & Co Ltd., Dr. Reddy’s Laboratories, Lupin Limited, Zydus Lifesciences Limited, Apotex Inc., Torrent Pharmaceuticals Limited, Panacea Biotech Ltd., Auro Laboratories Limited

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/biguanides-global-market-report

Which Region Holds The Greatest Opportunity For Biguanides Market Expansion?

Asia-Pacific was the largest region in the biguanides market in 2024. Middle East And Africa is expected to be the fastest-growing region in the forecast period. The regions covered in the biguanides market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15735&type=smp

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model